GlassScriptPhysician profile
Robert Cieslak
NPI 1083238554
$1,114.80
in general payments reported to CMS, 2019-2025
13 companies · $150 in 2025
The $150 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.00 · 2023: $328 · 2024: $583 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.81 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $174.61 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $147.39 | 2024-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.85 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $118.80 | 2023 | Verquvo |
| Philips North America LLC | $117.02 | 2024 | (P84) Igt Devices Systems |
| Biosense Webster, INC. | $113.36 | 2024 | Na |
| Chiesi USA, INC. | $95.79 | 2023-2024 | Cleviprex, Kengreal |
| Actelion Pharmaceuticals US, INC. | $69.99 | 2024 | Uptravi, Opsumit |
| Medtronic, INC. | $54.00 | 2022 | |
| Terumo Medical Corporation | $36.95 | 2023 | Glidewire, Angio-Seal |
| Recor Medical INC | $24.76 | 2025 | Paradise Ultrasound Renal Denervation System |
| Abiomed | $17.67 | 2024 | Impella |
| Novartis Pharmaceuticals Corporation | $16.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cieslak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.